{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-020666","form_type":"8-K","ticker":"GCAN","cik":"0001695473","company_name":"Greater Cannabis Company, Inc.","filed_at":"2021-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.250133+00:00","generated_at":"2026-06-29T08:57:19.033722+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GCAN signs licensing/research deal with Shaare Zedek for cannabinoid therapy targeting neuropsychiatric disorders","bullets":["Licensing covers novel cannabinoid therapeutic for autism, schizophrenia, Parkinson's, Alzheimer's, and other neuropsychiatric disorders.","Joint R&D agreement with Shaare Zedek Scientific, technology transfer arm of Jerusalem's Shaare Zedek Medical Center.","Dr. Adi Aran, SZMC pediatric neurology director and cannabis research pioneer, will lead continued clinical program.","Director David Tavor resigned effective August 19, 2021.","No financial terms of the agreements were disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-020666","json":"https://secwatch.observer/filing/0001493152-21-020666.json","markdown":"https://secwatch.observer/filing/0001493152-21-020666.md","text":"https://secwatch.observer/filing/0001493152-21-020666.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1695473/000149315221020666/0001493152-21-020666-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1695473/000149315221020666/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T08:57:19.033722+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0fcc61cf4e","claim":"David Tavor resigned as director at Greater Cannabis Company, Inc..","evidence_excerpt":"Effective August 19, 2021, David Tavor resigned as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1695473/000149315221020666/0001493152-21-020666-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}